Appointed by House Speaker:
Christian J. Miele
Dan K. Morhaim
Joseline Pena-Melnyk
Sheree Sample-Hughes
Staff: Erin R. Hopwood; David A. Smulski
c/o Department of Legislative Services
Legislative Services Building, 90 State Circle, Annapolis, MD 21401
(410) 946-5350, (301) 970-5350
The Joint Committee on Behavioral Health and Opioid Use Disorders was authorized in June 2015 (Chapter 464, Acts of 2015).
The Committee oversees the Prescription Drug Monitoring Program, and State and local programs to treat and reduce behavioral health and opioid use disorders. The Committee also is to review the final report of the Governor's Heroin and Opioid Emergency Task Force, and review and monitor the work of the Governor's Inter-Agency Heroin and Opioid Coordinating Council.
Ten members constitute the Committee: five senators appointed by the Senate President and five delegates appointed by the House Speaker (Code State Government Article, sec. 2-10A-02).
© Copyright Maryland State Archives